A randomized phase III comparison of single-modality ABVD with a strategy that includes radiation therapy in patients with early-stage Hodgkin's disease: The HD-6 trial of the National Cancer Institute of Canada Clinical Trials Group (Eastern Cooperative Oncology Group Trial JHD06).

被引：0
|
作者：
Meyer, R
Gospodarowicz, M
Connors, J
Pearcey, R
Bezjak, A
Wells, W
Burns, B
Winter, J
Horning, S
Dar, R
Djurfeld, M
Shepherd, L
Ding, KY
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Hamilton Reg Canc Ctr, Hamilton, ON L8V 1C3, Canada
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[6] Ottawa Hosp, Ottawa, ON, Canada
[7] Northwestern Univ, Chicago, IL 60611 USA
[8] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[9] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[10] Queens Univ, Natl Canc Inst Canada, Clin Trials Grp, Kingston, ON, Canada
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：26A / 26A
页数：1
相关论文
共 5 条
  • [1] Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
    Meyer, RM
    Gospodarowicz, MK
    Connors, JM
    Pearcey, RG
    Bezjak, A
    Wells, WA
    Burns, BE
    Winter, JN
    Horning, SJ
    Dar, AR
    Djurfeldt, MS
    Ding, K
    Shepherd, LE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4634 - 4642
  • [2] Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
    Gordon, Leo I.
    Hong, Fangxin
    Fisher, Richard I.
    Bartlett, Nancy L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Gospodarowicz, Mary
    Advani, Ranjana
    Kahl, Brad S.
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph M.
    Hoppe, Richard T.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 684 - 691
  • [3] A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)
    Gordon, Leo I.
    Hong, Fanxing
    Fisher, Richard I.
    Bartlett, Nancy L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Gospodarowicz, Mary
    Advani, Ranjana
    Kahl, Brad
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Hoppe, Richard
    Horning, Sandra J.
    BLOOD, 2010, 116 (21) : 185 - 185
  • [4] Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
    Rosenbrock, Johannes
    Kaul, Helen
    Oertel, Michael
    Celik, Eren
    Linde, Philipp
    Fan, Jiaqi
    Eichenauer, Dennis A.
    Broeckelmann, Paul J.
    von Tresckow, Bastian
    Kobe, Carsten
    Dietlein, Markus
    Fuchs, Michael
    Borchmann, Peter
    Eich, Hans Theodor
    Baues, Christian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (05): : 1344 - 1352
  • [5] A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinurn containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study
    Hirte, H.
    Vergote, I. B.
    Jeffrey, J. R.
    Grimshaw, R. N.
    Coppieters, S.
    Schwartz, B.
    Tu, D.
    Sadura, A.
    Brundage, M.
    Seymour, L.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 300 - 308
1